April 9, 2026
(Wednesday)
The Market Just Gave You a Perfect Lesson in Recency Bias
Yesterday, on April 8, 2026, Indian markets exploded higher — the SENSEX surged 2,946 points (3.95%) to close at 77,562 while NIFTY 50 rocketed 874 points (3.78%) to settle at 23,997. The Iran-US ceasefire announcement sent investors into a buying frenzy. Social media was flooded with “bull market is back!” posts.
Today? Markets opened lower. The SENSEX slipped to around 77,154, down over 400 points. NIFTY 50 retreated to approximately 23,764, losing over 230 points. Profit-booking, lingering geopolitical concerns about the ceasefire’s fragility, and FII selling of ₹2,812 crore suddenly changed the narrative. Now the same social media accounts are posting “crash coming!” warnings.
This, dear investor, is recency bias in real-time.
You just watched millions of investors make decisions based entirely on what happened in the last 24 hours — not on what a company is actually worth, not on decade-long fundamentals, not on business quality. They bought because yesterday was green. They’re panicking because today is red. This is exactly how retail investors destroy their own wealth — and today’s lesson on recency bias might be the single most important mental model you ever learn.
What Exactly Is Recency Bias?
Recency bias is a cognitive distortion where your brain assigns disproportionate weight to the most recent events, experiences, or information — while systematically ignoring the broader historical context. In neuroscience, this is linked to the “availability heuristic” — your brain retrieves recent memories more easily, and mistakenly treats “easy to remember” as “more important.”
In investing, recency bias manifests in devastating ways:
After a rally: Investors assume the market will keep rising. They pile in at the top, convinced that the recent trend is the new normal. After yesterday’s 4% surge, how many investors bought stocks at the highest prices of the week? Millions.
After a crash: Investors assume the world is ending. They sell at the bottom, convinced the recent decline will continue forever. During the April 2026 tariff panic when NIFTY fell nearly 8%, how many investors panic-sold their quality holdings? Lakhs.
The cruel irony: Recency bias makes you do the exact opposite of what creates wealth. You buy when prices are high (because recent news is positive) and sell when prices are low (because recent news is negative). As Warren Buffett says: “Be fearful when others are greedy, and greedy when others are fearful.”
SEBI’s Devastating Data: 9 Out of 10 Lose Money in F&O
Recency bias is perhaps the number one driver of F&O losses in India. SEBI’s own study confirmed that 9 out of 10 individual traders in the equity Futures & Options segment incurred net losses. These aren’t unlucky people — they’re intelligent individuals whose brains are wired to chase recent trends. They see NIFTY up 4% in one day and buy call options expecting another 4% tomorrow. They see a red day and buy puts expecting a crash. Each time, they’re trading based on what just happened — not on what the business fundamentals say.
This is exactly why we at Multibagger Shares relentlessly advocate for quality stock picking and long-term value investing over F&O gambling. The F&O market is essentially a recency bias amplification machine — it rewards short-term pattern matching (which doesn’t work) and punishes patient, fundamental analysis (which does).
The Five Deadly Forms of Recency Bias in Indian Markets
1. Performance Chasing
When a stock or sector has performed well recently, investors pile in assuming the trend will continue. In 2024, defense stocks rallied 200-300%, and every retail investor wanted in — at the top. Many of those stocks have since corrected 40-50% from their highs. The investors who bought at peak prices weren’t analyzing order books or profit margins — they were simply chasing recent performance.
2. Sector Rotation Whiplash
Indian investors constantly rotate between “hot” sectors based on the last quarter’s results. IT stocks outperform? Everyone moves to IT. Pharma rallies? Everyone dumps IT for pharma. This constant churn — driven entirely by recent performance — generates massive transaction costs and tax liabilities while delivering returns far below a simple buy-and-hold strategy on quality businesses.
3. Bull Market Overconfidence
After extended bull runs, investors begin to believe that making money in the stock market is easy. They increase position sizes, take on leverage, and abandon their research discipline. This is why the biggest losses always come after the biggest rallies — the 2008 crash, the 2020 COVID crash, and the periodic corrections in 2022, 2024, and early 2026 all wiped out investors who confused a rising tide with personal genius.
4. Bear Market Paralysis
Conversely, after prolonged declines, investors freeze. They stop investing entirely, convinced the market will never recover. The investors who stopped their SIPs during the March 2020 crash missed the greatest rally in Indian market history. Those who panic-sold during the April 2025 tariff correction missed the subsequent recovery. Bear market paralysis is just recency bias in reverse — your brain can’t imagine a future different from the recent past.
5. News Cycle Trading
Perhaps the most dangerous form: making investment decisions based on today’s headlines. Yesterday’s Iran-US ceasefire sent markets up 4%. Today’s news about potential ceasefire violations sent markets down 1%. Tomorrow will bring new headlines, new reactions, new panic or euphoria. None of this has anything to do with whether Titan Biotech’s products are selling well, whether their export revenue is growing, or whether their balance sheet is strengthening.
A Real-World Example: Titan Biotech (BSE: 524717)
Consider Titan Biotech — currently trading at approximately ₹454 (post-split, face value ₹2) with a market cap of around ₹1,877 crore. The stock has a 52-week range of ₹74.7 to ₹556, a ROCE of 16.9%, and ROE of 15.0%.
Now, imagine two investors:
Investor A (Recency Bias Victim): Sees Titan Biotech near its 52-week high of ₹556 in early 2026. Buys aggressively because “it’s been going up!” Then watches it correct to ₹454. Panics and sells at a 20% loss because “it’s been going down!” Classic recency bias — buying the recent uptrend, selling the recent downtrend.
Investor B (Fundamental Value Investor): Knows that Titan Biotech has grown revenue at 15%+ CAGR over a decade, exports to 100+ countries, has an operating margin that doubled from 10% to 19%, is virtually debt-free with a D/E ratio of 0.02x, and has a ₹38 crore cash war chest. Investor B doesn’t care what the stock did yesterday. Investor B owns the business — and the business is thriving.
This is the fundamental difference between an investor controlled by recency bias and one liberated by deep fundamental analysis. Our Value Investing Course teaches you exactly this framework.
The Concentrated Portfolio Advantage Against Recency Bias
Here’s a truth that every master investor lives by: wide diversification actually amplifies recency bias, while concentrated portfolios cure it.
As Warren Buffett famously said: “Wide diversification is only required when investors do not understand what they are doing.”
When you own 50 stocks, you can’t possibly know each business deeply enough to hold through volatility. When NIFTY drops 4% in a day, you have no idea which of your 50 holdings deserve to be held and which don’t — so your brain defaults to recency bias: “Everything is falling, sell everything!”
But when you own 5-10 deeply researched, high-conviction positions — businesses you’ve analyzed through a rigorous 95-factor framework — you KNOW that a one-day market move is noise. You know the business inside out. You know the management quality, the moat, the financial strength, the growth drivers. You can sit through a 4% crash or a 4% rally with complete equanimity because your investment thesis is built on decades of business fundamentals, not yesterday’s headlines.
This is what the greatest investors — Buffett, Munger, Pabrai, Jhunjhunwala — actually practice. They made their fortunes through conviction in their best ideas, not by spreading capital thin across mediocre picks. Concentration forces you to do the deep work that makes you immune to recency bias.
Six Practical Strategies to Defeat Recency Bias
1. Write Down Your Investment Thesis BEFORE You Buy
For every stock you own, write a one-page thesis explaining WHY you own it. Include specific fundamental metrics: revenue growth rate, operating margins, ROCE, debt levels, cash flow quality, management track record. When the market crashes and your brain screams “SELL!”, re-read your thesis. Has the business changed? Or has only the market’s recent mood changed? Nine times out of ten, it’s just mood.
2. Use the “10-Year Newspaper Test”
Before making any investment decision based on recent news, ask yourself: “Will this news story matter in 10 years?” Yesterday’s Iran-US ceasefire? Probably not. Today’s profit-booking session? Definitely not. But Titan Biotech’s expansion into new export markets, their 100+ product portfolio, their debt-free status? Those compound over decades. Focus on what matters in the long run.
3. Study Market History — Not Just Recent History
The SENSEX was at 100 in 1984. Today it’s at approximately 77,000. That’s a 770x return over 42 years. Along the way, it endured the Harshad Mehta scam, the Asian financial crisis, the dot-com bust, the 2008 global financial crisis, demonetization, COVID-19, and countless other “crises” that felt existential at the time. Every single one was followed by new highs. Recency bias makes you focus on this week’s crisis. Market history shows you the unstoppable trajectory of India’s economic growth.
4. Implement a Mandatory 48-Hour Cooling Period
Never buy or sell a stock on the same day you make the decision. Wait 48 hours. If after two days of calm reflection, the decision still makes sense based on fundamentals (not recent price action), proceed. This simple rule eliminates 80% of recency-bias-driven trades.
5. Track Your Decisions and Outcomes
Keep an investment journal. Write down every buy and sell decision with your reasoning AT THE TIME. After 6 months, review your journal. You’ll be shocked at how many decisions were driven by “the stock was going up recently” or “the market was crashing recently” rather than any fundamental analysis. This self-awareness is the first step to defeating the bias.
6. Focus on Business Metrics, Not Stock Price
Instead of checking your portfolio’s daily P&L (which triggers recency bias every time), track the BUSINESS metrics of your holdings: quarterly revenue growth, operating margins, ROCE improvement, debt reduction, order book growth, capacity expansion. These metrics change slowly and predictably — they’re recency-bias-proof. The stock price is just noise around the fundamental value signal.
Today’s Market Context: Perfect Example in Action
With the SENSEX around 77,000 levels and NIFTY 50 near 23,764 today — pulling back after yesterday’s euphoric rally — you have a perfect opportunity to practice defeating recency bias. The RBI has kept the repo rate unchanged at 5.25%, projecting 6.9% GDP growth for FY27. India’s structural growth story remains intact. The ceasefire concerns creating today’s pullback are the definition of short-term noise.
The investors who will create generational wealth from Indian markets are not the ones reacting to today’s 1% decline or yesterday’s 4% rally. They are the ones who identified quality businesses trading at reasonable valuations, built concentrated portfolios of their best ideas, and held through every news cycle with the patience and discipline that recency bias cannot touch.
As we always say at Multibagger Shares: invest based on the quality of the business, not the mood of the market. Your portfolio will thank you in a decade.
📢 Join Our Telegram Channel
Get daily value investing lessons, stock analysis & Titan Biotech updates — delivered straight to your phone!
✈️ Join @longtermequityy on Telegram
🔔 Free • No spam • Value investing insights daily
Disclaimer: This article is for educational and informational purposes only. It is not investment advice, and not a buy, sell, or hold recommendation on any stock mentioned, including Titan Biotech Limited. Equity markets carry risk; please do your own research or consult a qualified professional before making investment decisions.
